Sure, but a PR screw up. Aussie biotech company story was a good one and one that is more likely to be supported here in Aus, get some good media coverage, help bring investors etc. Every sale would have helped, our market penetration overseas has been hopeless. I'm not sure the market will take a great deal of interest in the TGA approval now anyway, it's all a bit late and isn't going to solve the underlying issues the company is now facing.
Farewell, punks, page-22
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.25 |
Change
-0.250(1.61%) |
Mkt cap ! $322.3M | |||
| Open | High | Low | Value | Volume |
| $15.50 | $15.50 | $14.80 | $140.4K | 9.315K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 297 | $15.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.25 | 1300 | 2 |
View Market Depth
| Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |